Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups (2012)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FMRP ; FALCÃO, ROBERTO PASSETTO - FMRP
- Unidade: FMRP
- DOI: 10.1158/1078-0432.CCR-12-0087
- Subjects: LEUCEMIA MIELOIDE AGUDA; MEDULA ÓSSEA; NÚCLEO CELULAR; ESTUDOS DE COORTES
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2012
- Source:
- Título: Clinical Cancer Research
- ISSN: 1078-0432
- Volume/Número/Paginação/Ano: v. 18, n. 12, p. 3293-3304, 2012
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
GADJI, Macoura et al. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, v. 18, n. 12, p. 3293-3304, 2012Tradução . . Disponível em: https://doi.org/10.1158/1078-0432.CCR-12-0087. Acesso em: 07 maio 2026. -
APA
Gadji, M., Awe, J. A., Rodrigues, P., Kumar, R., Houston, D. S., Klewes, L., et al. (2012). Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, 18( 12), 3293-3304. doi:10.1158/1078-0432.CCR-12-0087 -
NLM
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2026 maio 07 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087 -
Vancouver
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2026 maio 07 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087 - P-gp function and expression in decreased in hCG-PML-RAR'alfa' transgenic mice before the development of leukemia
- Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia
- Diminuição da função da P-gp precede o desenvolvimento da Leucemia Promielocítica aguda em camundongos trangênicos PML-RAR'alfa'
- Leucemia linfocítica crônica biclonal
- Segmental amplification of MLL gene associated with high expression of AURKA and AURKB genes in a case of acute monoblastic leukemia with complex karyotype
- A 23-year-old woman with 11q-chronic lymphocytic leukemia
- Leucemia linfóide aguda em adultos e crianças: Características morfológicas e imunofenotípicas
- FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities
- High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia
- The microgranular variant of acute promyelocytic leukemia also presents the flow cytometric pattern of CD13, CD34 and CD15 expression characteristic of PML-RAR'alfa' gene rearrangement
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
